P70336
Gene name |
Rock2 |
Protein name |
Rho-associated protein kinase 2 |
Names |
Rho-associated, coiled-coil-containing protein kinase 2, Rho-associated, coiled-coil-containing protein kinase II, ROCK-II, p164 ROCK-2 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:19878 |
EC number |
2.7.11.1: Protein-serine/threonine kinases |
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
92-354 (Catalytic kinase domain) |
Relief mechanism |
Partner binding |
Assay |
|
Target domain |
92-354 (Catalytic kinase domain) |
Relief mechanism |
Partner binding |
Assay |
|
Accessory elements
231-255 (Activation loop from InterPro)
Target domain |
39-417 (Catalytic domain of the Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2) |
Relief mechanism |
|
Assay |
|
References
- Riento K et al. (2003) "Rocks: multifunctional kinases in cell behaviour", Nature reviews. Molecular cell biology, 4, 446-56
- Chen XQ et al. (2002) "Characterization of RhoA-binding kinase ROKalpha implication of the pleckstrin homology domain in ROKalpha function using region-specific antibodies", The Journal of biological chemistry, 277, 12680-8
- Leung T et al. (1996) "The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton", Molecular and cellular biology, 16, 5313-27
- Amano M et al. (1999) "The COOH terminus of Rho-kinase negatively regulates rho-kinase activity", The Journal of biological chemistry, 274, 32418-24
- Tan I et al. (2001) "Intermolecular and intramolecular interactions regulate catalytic activity of myotonic dystrophy kinase-related Cdc42-binding kinase alpha", Molecular and cellular biology, 21, 2767-78
Autoinhibited structure

Activated structure

1 structures for P70336
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-P70336-F1 | Predicted | AlphaFoldDB |
No variants for P70336
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
No variants for P70336 |
No associated diseases with P70336
10 regional properties for P70336
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Protein kinase domain | 92 - 354 | IPR000719 |
domain | AGC-kinase, C-terminal | 357 - 425 | IPR000961 |
domain | Pleckstrin homology domain | 1150 - 1351 | IPR001849 |
domain | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain | 1260 - 1315 | IPR002219 |
active_site | Serine/threonine-protein kinase, active site | 210 - 222 | IPR008271 |
domain | HR1 rho-binding domain | 497 - 573 | IPR011072 |
domain | ROCK, Rho binding domain | 978 - 1047 | IPR015008 |
binding_site | Protein kinase, ATP binding site | 98 - 121 | IPR017441 |
domain | Rho-associated protein kinase 2, catalytic domain | 39 - 417 | IPR029878 |
domain | Rho-associated protein kinase 2, HR1 domain | 505 - 571 | IPR037311 |
Functions
Description | ||
---|---|---|
EC Number | 2.7.11.1 | Protein-serine/threonine kinases |
Subcellular Localization |
|
|
PANTHER Family | ||
PANTHER Subfamily | ||
PANTHER Protein Class | ||
PANTHER Pathway Category | No pathway information available |
10 GO annotations of cellular component
Name | Definition |
---|---|
centrosome | A structure comprised of a core structure (in most organisms, a pair of centrioles) and peripheral material from which a microtubule-based structure, such as a spindle apparatus, is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells, though in animal cells it changes continually during the cell-division cycle. |
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
cytoplasmic ribonucleoprotein granule | A ribonucleoprotein granule located in the cytoplasm. |
cytoskeleton | A cellular structure that forms the internal framework of eukaryotic and prokaryotic cells. The cytoskeleton includes intermediate filaments, microfilaments, microtubules, the microtrabecular lattice, and other structures characterized by a polymeric filamentous nature and long-range order within the cell. The various elements of the cytoskeleton not only serve in the maintenance of cellular shape but also have roles in other cellular functions, including cellular movement, cell division, endocytosis, and movement of organelles. |
cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
glutamatergic synapse | A synapse that uses glutamate as a neurotransmitter. |
nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
Schaffer collateral - CA1 synapse | A synapse between the Schaffer collateral axon of a CA3 pyramidal cell and a CA1 pyramidal cell. |
spindle pole centrosome | A centrosome from which one pole of a mitotic or meiotic spindle is organized. |
8 GO annotations of molecular function
Name | Definition |
---|---|
ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
metal ion binding | Binding to a metal ion. |
protein kinase activity | Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP. |
protein serine kinase activity | Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate. |
protein serine/threonine kinase activity | Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate. |
protein serine/threonine/tyrosine kinase activity | Catalysis of the reactions: ATP + a protein serine = ADP + protein serine phosphate; ATP + a protein threonine = ADP + protein threonine phosphate; and ATP + a protein tyrosine = ADP + protein tyrosine phosphate. |
Rho-dependent protein serine/threonine kinase activity | Rho GTPase-dependent catalysis of the reaction: ATP + a protein = ADP + a phosphoprotein. |
small GTPase binding | Binding to a small monomeric GTPase. |
56 GO annotations of biological process
Name | Definition |
---|---|
actin cytoskeleton organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins. |
actomyosin structure organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures containing both actin and myosin or paramyosin. The myosin may be organized into filaments. |
blood vessel diameter maintenance | Any process that modulates the diameter of blood vessels. |
cellular response to acetylcholine | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an acetylcholine stimulus. |
cellular response to testosterone stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a testosterone stimulus. |
centrosome duplication | The replication of a centrosome, a structure comprised of a pair of centrioles and peri-centriolar material from which a microtubule spindle apparatus is organized. |
cortical actin cytoskeleton organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of actin-based cytoskeletal structures in the cell cortex, i.e. just beneath the plasma membrane. |
dendrite morphogenesis | The process in which the anatomical structures of a dendrite are generated and organized. |
embryonic morphogenesis | The process in which anatomical structures are generated and organized during the embryonic phase. The embryonic phase begins with zygote formation. The end of the embryonic phase is organism-specific. For example, it would be at birth for mammals, larval hatching for insects and seed dormancy in plants. |
epithelial to mesenchymal transition | A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell. |
extrinsic apoptotic signaling pathway via death domain receptors | The series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with a ligand binding to a death domain receptor on the cell surface, and ends when the execution phase of apoptosis is triggered. |
I-kappaB kinase/NF-kappaB signaling | The process in which a signal is passed on to downstream components within the cell through the I-kappaB-kinase (IKK)-dependent activation of NF-kappaB. The cascade begins with activation of a trimeric IKK complex (consisting of catalytic kinase subunits IKKalpha and/or IKKbeta, and the regulatory scaffold protein NEMO) and ends with the regulation of transcription of target genes by NF-kappaB. In a resting state, NF-kappaB dimers are bound to I-kappaB proteins, sequestering NF-kappaB in the cytoplasm. Phosphorylation of I-kappaB targets I-kappaB for ubiquitination and proteasomal degradation, thus releasing the NF-kappaB dimers, which can translocate to the nucleus to bind DNA and regulate transcription. |
mitotic cytokinesis | A cell cycle process that results in the division of the cytoplasm of a cell after mitosis, resulting in the separation of the original cell into two daughter cells. |
mRNA destabilization | Any process that decreases the stability of an mRNA molecule, making it more vulnerable to degradative processes. Messenger RNA is the intermediate molecule between DNA and protein. It includes UTR and coding sequences. It does not contain introns. |
negative regulation of angiogenesis | Any process that stops, prevents, or reduces the frequency, rate or extent of angiogenesis. |
negative regulation of bicellular tight junction assembly | Any process that stops, prevents or reduces the frequency, rate or extent of tight junction assembly. |
negative regulation of gene expression | Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
negative regulation of myosin-light-chain-phosphatase activity | Any process that stops, prevents, or reduces the frequency, rate or extent of myosin-light-chain-phosphatase activity. |
negative regulation of nitric oxide biosynthetic process | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide. |
negative regulation of protein localization to lysosome | Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to lysosome. |
neural tube closure | The last step in the formation of the neural tube, where the paired neural folds are brought together and fuse at the dorsal midline. |
peptidyl-serine phosphorylation | The phosphorylation of peptidyl-serine to form peptidyl-O-phospho-L-serine. |
peptidyl-threonine phosphorylation | The phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine. |
positive regulation of amyloid precursor protein catabolic process | Any process that activates or increases the frequency, rate or extent of amyloid precursor protein catabolic process. |
positive regulation of amyloid-beta formation | Any process that activates or increases the frequency, rate or extent of amyloid-beta formation. |
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process | Any process that activates or increases the frequency, rate or extent of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process. |
positive regulation of cardiac muscle hypertrophy | Any process that increases the rate, frequency or extent of the enlargement or overgrowth of all or part of the heart due to an increase in size (not length) of individual cardiac muscle fibers, without cell division. |
positive regulation of cell migration | Any process that activates or increases the frequency, rate or extent of cell migration. |
positive regulation of centrosome duplication | Any process that increases the frequency, rate or extent of centrosome duplication. Centrosome duplication is the replication of a centrosome, a structure comprised of a pair of centrioles and peri-centriolar material from which a microtubule spindle apparatus is organized. |
positive regulation of connective tissue growth factor production | Any process that activates or increases the frequency, rate, or extent of connective tissue growth factor production. |
positive regulation of connective tissue replacement | Any process that activates or increases the frequency, rate or extent of connective tissue replacement. |
positive regulation of endothelial cell migration | Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium. |
positive regulation of fibroblast growth factor production | Any process that increases the rate, frequency or extent of the appearance of a fibroblast growth factor due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. |
positive regulation of gene expression | Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
positive regulation of MAPK cascade | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade. |
positive regulation of protein localization to early endosome | Any process that activates or increases the frequency, rate or extent of protein localization to early endosome. |
positive regulation of protein phosphorylation | Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. |
positive regulation of stress fiber assembly | Any process that activates or increases the frequency, rate or extent of the assembly of a stress fiber, a bundle of microfilaments and other proteins found in fibroblasts. |
postsynaptic actin cytoskeleton organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins in the postsynaptic actin cytoskeleton. |
protein localization to plasma membrane | A process in which a protein is transported to, or maintained in, a specific location in the plasma membrane. |
protein phosphorylation | The process of introducing a phosphate group on to a protein. |
regulation of angiotensin-activated signaling pathway | Any process that modulates the frequency, rate or extent of the angiotensin-activated signaling pathway. |
regulation of cell junction assembly | Any process that modulates the frequency, rate or extent of cell junction assembly. |
regulation of cellular response to hypoxia | Any process that modulates the frequency, rate or extent of cellular response to hypoxia. |
regulation of circadian rhythm | Any process that modulates the frequency, rate or extent of a circadian rhythm. A circadian rhythm is a biological process in an organism that recurs with a regularity of approximately 24 hours. |
regulation of establishment of endothelial barrier | Any process that modulates the frequency, rate or extent of establishment of endothelial barrier. |
regulation of keratinocyte differentiation | Any process that modulates the frequency, rate or extent of keratinocyte differentiation. |
regulation of nervous system process | Any process that modulates the frequency, rate or extent of a neurophysiological process, an organ system process carried out by any of the organs or tissues of the nervous system. |
regulation of protein metabolic process | Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving a protein. |
response to angiotensin | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an angiotensin stimulus. Angiotensin is any of three physiologically active peptides (angiotensin II, III, or IV) processed from angiotensinogen. |
response to ischemia | Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a inadequate blood supply. |
response to transforming growth factor beta | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus. |
Rho protein signal transduction | The series of molecular signals within the cell that are mediated by a member of the Rho family of proteins switching to a GTP-bound active state. |
rhythmic process | Any process pertinent to the generation and maintenance of rhythms in the physiology of an organism. |
smooth muscle contraction | A process in which force is generated within smooth muscle tissue, resulting in a change in muscle geometry. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis. Smooth muscle differs from striated muscle in the much higher actin/myosin ratio, the absence of conspicuous sarcomeres and the ability to contract to a much smaller fraction of its resting length. |
viral RNA genome replication | The replication of a viral RNA genome. |
15 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q28021 | ROCK2 | Rho-associated protein kinase 2 | Bos taurus (Bovine) | SS |
Q9W1B0 | gek | Serine/threonine-protein kinase Genghis Khan | Drosophila melanogaster (Fruit fly) | SS |
Q9Y5S2 | CDC42BPB | Serine/threonine-protein kinase MRCK beta | Homo sapiens (Human) | SS |
Q5VT25 | CDC42BPA | Serine/threonine-protein kinase MRCK alpha | Homo sapiens (Human) | EV |
Q13464 | ROCK1 | Rho-associated protein kinase 1 | Homo sapiens (Human) | SS |
O75116 | ROCK2 | Rho-associated protein kinase 2 | Homo sapiens (Human) | SS |
Q80UW5 | Cdc42bpg | Serine/threonine-protein kinase MRCK gamma | Mus musculus (Mouse) | PR |
Q7TT50 | Cdc42bpb | Serine/threonine-protein kinase MRCK beta | Mus musculus (Mouse) | SS |
Q3UU96 | Cdc42bpa | Serine/threonine-protein kinase MRCK alpha | Mus musculus (Mouse) | SS |
P70335 | Rock1 | Rho-associated protein kinase 1 | Mus musculus (Mouse) | SS |
M3TYT0 | ROCK2 | Rho-associated protein kinase 2 | Sus scrofa (Pig) | SS |
O54874 | Cdc42bpa | Serine/threonine-protein kinase MRCK alpha | Rattus norvegicus (Rat) | SS |
Q7TT49 | Cdc42bpb | Serine/threonine-protein kinase MRCK beta | Rattus norvegicus (Rat) | SS |
Q63644 | Rock1 | Rho-associated protein kinase 1 | Rattus norvegicus (Rat) | SS |
Q62868 | Rock2 | Rho-associated protein kinase 2 | Rattus norvegicus (Rat) | EV |
10 | 20 | 30 | 40 | 50 | 60 |
MSRPPPTGKM | PGAPEAAPGD | GAGAGRQRKL | EALIRDPRSP | INVESLLDGL | NSLVLDLDFP |
70 | 80 | 90 | 100 | 110 | 120 |
ALRKNKNIDN | FLNRYEKIVK | KIRGLQMKAE | DYDVVKVIGR | GAFGEVQLVR | HKASQKVYAM |
130 | 140 | 150 | 160 | 170 | 180 |
KLLSKFEMIK | RSDSAFFWEE | RDIMAFANSP | WVVQLFCAFQ | DDRYLYMVME | YMPGGDLVNL |
190 | 200 | 210 | 220 | 230 | 240 |
MSNYDVPEKW | AKFYTAEVVL | ALDAIHSMGL | IHRDVKPDNM | LLDKHGHLKL | ADFGTCMKMD |
250 | 260 | 270 | 280 | 290 | 300 |
ETGMVHCDTA | VGTPDYISPE | VLKSQGGDGY | YGRECDWWSV | GVFLFEMLVG | DTPFYADSLV |
310 | 320 | 330 | 340 | 350 | 360 |
GTYSKIMDHK | NSLCFPEDTE | ISKHAKNLIC | AFLTDREVRL | GRNGVEEIKQ | HPFFKNDQWN |
370 | 380 | 390 | 400 | 410 | 420 |
WDNIRETAAP | VVPELSSDID | SSNFDDIEDD | KGDVETFPIP | KAFVGNQLPF | IGFTYFRENL |
430 | 440 | 450 | 460 | 470 | 480 |
LLSDSPPCRE | NDAIQTRKSE | ESQEIQKKLY | ALEEHLSSEV | QAKEELEQKC | KSINTRLEKT |
490 | 500 | 510 | 520 | 530 | 540 |
AKELEEEITL | RKSVESTLRQ | LEREKALLQH | KNAEYQRKAD | HEADKKRNLE | NDVNSLKDQL |
550 | 560 | 570 | 580 | 590 | 600 |
EDLKKRNQSS | QISTEKVNQL | QKQLDEANAL | LRTESDTAAR | LRKTQAESSK | QIQQLESNNR |
610 | 620 | 630 | 640 | 650 | 660 |
DLQDKNCLLE | TAKLKLEKEF | INLQSALESE | RRDRTHGSEI | INDLQGRISG | LEEDLKTGKA |
670 | 680 | 690 | 700 | 710 | 720 |
LLAKVELEKR | QLQEKLTDLE | KEKSNMEIDM | TYQLKVIQQS | LEQEEAEHKT | TKARLADKNK |
730 | 740 | 750 | 760 | 770 | 780 |
IYESIEEAKS | EAMKEMEKKL | LEERSLKQKV | ENLLLEAEKR | CSILDCDLKQ | SQQKLNELLK |
790 | 800 | 810 | 820 | 830 | 840 |
QKDVLNEDVR | NLTLKIEQET | QKRCLMQNDL | KMQTQQVNTL | KMSEKQIKQE | NNHLMEMKMN |
850 | 860 | 870 | 880 | 890 | 900 |
LEKQNTELRK | ERQDADGQMK | ELQDQLEAEQ | YFSTLYKTQV | RELKEENEEK | TKLCKELQQK |
910 | 920 | 930 | 940 | 950 | 960 |
KQDLQDERDS | LAAQLEITLT | KADSEQLARS | IAEEQYSDLE | KEKIMKELEI | KEMMARHKQE |
970 | 980 | 990 | 1000 | 1010 | 1020 |
LTEKDTTIAS | LEETNRTLTS | DVANLANEKE | ELNNKLKDSQ | EQLSKLKDEE | MSAAAIKAQF |
1030 | 1040 | 1050 | 1060 | 1070 | 1080 |
EKQLLNERTL | KTQAVNKLAE | IMNRKEPVKR | GSDTDVRRKE | KENRKLHMEL | KSEREKLTQQ |
1090 | 1100 | 1110 | 1120 | 1130 | 1140 |
MIKYQKELNE | MQAQIAEESQ | IRIELQMTLD | SKDSDIEQLR | SQLQALHIGM | DSSSIGSGPG |
1150 | 1160 | 1170 | 1180 | 1190 | 1200 |
DAEPDDGFPE | SRLEGWLSLP | VRNNTKKFGW | VKKYVIVSSK | KILFYDSEQD | KEQSNPYMVL |
1210 | 1220 | 1230 | 1240 | 1250 | 1260 |
DIDKLFHVRP | VTQTDVYRAD | AKEIPRIFQI | LYANEGESKK | EPEFPVEPVG | EKSNYICHKG |
1270 | 1280 | 1290 | 1300 | 1310 | 1320 |
HEFIPTLYHF | PTNCEACMKP | LWHMFKPPPA | LECRRCHIKC | HKDHMDKKEE | IIAPCKVYYD |
1330 | 1340 | 1350 | 1360 | 1370 | 1380 |
ISSAKNLLLL | ANSTEEQQKW | VSRLVKKIPK | KPPAPDPFAR | SSPRTSMKIQ | QNQSIRRPSR |
QLAPNKPS |